34298-85-6 Usage
General Description
4,5-dihydroxy-7-methyl-9,10-dioxo-9,10-dihydroanthracen-2-yl alpha-D-galactopyranoside is a complex chemical compound with potential biological activity. It is a glycoside, meaning it contains a sugar molecule attached to a non-sugar compound. The anthracen backbone in the compound suggests potential for pharmaceutical applications, as anthracen derivatives have been studied for their anti-inflammatory, anticancer, and antiviral properties. The presence of the sugar moiety indicates potential for interactions with biological systems and could make the compound useful for drug delivery or as a potential bioactive compound. However, further research is needed to understand the full potential and applications of 4,5-dihydroxy-7-methyl-9,10-dioxo-9,10-dihydroanthracen-2-yl alpha-D-galactopyranoside.
Check Digit Verification of cas no
The CAS Registry Mumber 34298-85-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,9 and 8 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 34298-85:
(7*3)+(6*4)+(5*2)+(4*9)+(3*8)+(2*8)+(1*5)=136
136 % 10 = 6
So 34298-85-6 is a valid CAS Registry Number.
34298-85-6Relevant articles and documents
Two trifunctional leloir glycosyltransferases as biocatalysts for natural products glycodiversification
Pandey, Ramesh Prasad,Bashyal, Puspalata,Parajuli, Prakash,Yamaguchi, Tokutaro,Sohng, Jae Kyung
supporting information, p. 8058 - 8064 (2019/10/14)
Two promiscuous Bacillus licheniformis glycosyltransferases, YdhE and YojK, exhibited prominent stereospecific but nonregiospecific glycosylation activity of 20 different classes of 59 structurally different natural and non-natural products. Both enzymes transferred various sugars at three nucleophilic groups (OH, NH2, SH) of diverse compounds to produce O-, N-, and S-glycosides. The enzymes also displayed a catalytic reversibility potential for a one-pot transglycosylation, thus bestowing a cost-effective application in biosynthesis of glycodiversified natural products in drug discovery.
